Literature DB >> 7916992

A connexin 43 antisense vector reduces the ability of normal cells to inhibit the foci formation of transformed cells.

G S Goldberg1, K D Martyn, A F Lau.   

Abstract

Antisense gene constructs have been very useful in the functional analysis of genes and their products. In this report we used a connexin 43 (Cx43) antisense gene construct to study the role that heterologous gap-junctional intracellular communication (GJIC) plays in the ability of untransformed fibroblasts to suppress the foci-forming ability of src oncogene-transformed cells. Untransformed Rat-1 fibroblasts transfected with the Cx43 antisense DNA construct showed marked decreases in Cx43 RNA and protein, which were accompanied by a corresponding decrease in GJIC. These Cx43 antisense-transfected cells maintained normal cell morphology, growth rates, and saturation densities and did not grow in soft-agar suspension. However, in coculture experiments, the Cx43 antisense cells were less effective than vector-alone-transfected, sense-transfected, and untransfected cells at inhibiting foci formation of pp60v-src-transformed cells. These effects of junctionally competent, normal cells were associated with the existence of heterologous GJIC with the transformed cells and did not appear to result from the elaboration of a stable, diffusible inhibitory factor. Thus, gap-junction-mediated transfer of putative regulatory molecules may play a role in the ability of untransformed cells to suppress the expression of certain properties of transformed cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916992     DOI: 10.1002/mc.2940110208

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  11 in total

1.  Formation of heteromeric gap junction channels by connexins 40 and 43 in vascular smooth muscle cells.

Authors:  D S He; J X Jiang; S M Taffet; J M Burt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

Review 2.  Regulation of gap junctions by tyrosine protein kinases.

Authors:  Bonnie J Warn-Cramer; Alan F Lau
Journal:  Biochim Biophys Acta       Date:  2004-03-23

3.  Src phosphorylates Cas on tyrosine 253 to promote migration of transformed cells.

Authors:  Gary S Goldberg; David B Alexander; Patricia Pellicena; Zhong-Yin Zhang; Hiroyuki Tsuda; W Todd Miller
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

4.  Anti-breast cancer agents, quinolines, targeting gap junction.

Authors:  Julie Bernzweig; Brian Heiniger; Keshar Prasain; Jianyu Lu; Duy H Hua; Thu A Nguyen
Journal:  Med Chem       Date:  2011-09       Impact factor: 2.745

Review 5.  Impact of interactions between normal and transformed epithelial cells and the relevance to cancer.

Authors:  Catherine Hogan
Journal:  Cell Mol Life Sci       Date:  2011-08-30       Impact factor: 9.261

6.  Maintaining connexin43 gap junctional communication in v-Src cells does not alter growth properties associated with the transformed phenotype.

Authors:  Bonnie J Warn-Cramer; Rui Lin; Kendra Martyn; Carrie V Guyette; Alan F Lau
Journal:  Cell Commun Adhes       Date:  2003 Jul-Dec

7.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

8.  Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility.

Authors:  Harini Krishnan; Jhon A Ochoa-Alvarez; Yongquan Shen; Evan Nevel; Meenakshi Lakshminarayanan; Mary C Williams; Maria I Ramirez; W Todd Miller; Gary S Goldberg
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

9.  Properties and regulation of gap junctional hemichannels in the plasma membranes of cultured cells.

Authors:  H Li; T F Liu; A Lazrak; C Peracchia; G S Goldberg; P D Lampe; R G Johnson
Journal:  J Cell Biol       Date:  1996-08       Impact factor: 10.539

10.  Modulated gap junctional intercellular communication as a biomarker of PAH epigenetic toxicity: structure-function relationship.

Authors:  B L Upham; L M Weis; J E Trosko
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.